New York, NY, Dec. 12, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp., a Delaware corporation (the “Company”), reminds its stockholders that its 2024 Annual Meeting of Stockholders will be held 9:00 AM EST on December 23, 2024, at the Regus Conference Room at 35 Village Rd, Suite 100, Middleton, MA 01949, as per the Proxy Material mailed to shareholders on December 6, 2024.
Contacts:
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$1.84 |
| Daily Volume: | 15,410 |
| Market Cap: | US$3.420M |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
